Solventum (SOLV) Cash & Equivalents (2023 - 2026)

Solventum's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $561.0 million for Q1 2026.

• Quarterly Cash & Equivalents rose 5.06% year-over-year to $561.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561.0 million (up 5.06% YoY) and the FY2025 annual result came in at $878.0 million, up 15.22% from the prior year.
• Cash & Equivalents was $561.0 million for Q1 2026 at Solventum, down from $878.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.6 billion in Q3 2025 and bottomed at $194.0 million in Q4 2023.
• A 4-year average of $772.8 million and a median of $767.0 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 292.78% — and 2025, when it slumped 46.39%.
• Solventum's Cash & Equivalents stood at $194.0 million in 2023, then jumped by 292.78% to $762.0 million in 2024, then climbed by 15.22% to $878.0 million in 2025, then slumped by 36.1% to $561.0 million in 2026.
• Business Quant data shows SOLV's Cash & Equivalents at $561.0 million in Q1 2026, $878.0 million in Q4 2025, and $1.6 billion in Q3 2025.